Global ETD Search

Epidemiology of non-squamous non-small cell lung cancer in New Zealand: A focus on EGFR gene mutation

Aye, Phyu SinResearchSpace@Auckland2021

… that target Epidermal Growth Factor Receptor (EGFR) significantly improves disease outcomes for non-squamous Non-Small Cell Lung Cancer (NSCLC) patients with EGFR mutation. A better understanding is needed of the epidemiology of lung cancer in relation to EGFR mutation and strategies to …

auckland-ms Repository record for Epidemiology of non-squamous non-small cell lung cancer in New Zealand: A focus on EGFR gene mutation (opens in a new tab)

Clinical and molecular features of Epidermal Growth Factor Receptor (EGFR) mutation positive non-small-cell lung cancer patients treated with tyrosine kinase inhibitors: predictive and prognostic role of co-mutations

Scagliotti, Giorgio Vittorio, Novello, Silvia, Bussolino, Federico, Bironzo, PaoloUniversità degli Studi di Torino2021

unito Repository record for Clinical and molecular features of Epidermal Growth Factor Receptor (EGFR) mutation positive non-small-cell lung cancer patients treated with tyrosine kinase inhibitors: predictive and prognostic role of co-mutations (opens in a new tab)

Innovative Methods for Outcome-Based Pricing of Treatments from the US Payer Perspective (The Six Delta Platform)

Alkhatib, NimerThe University of Arizona.2020

… (NSCLC) with epidermal growth factor receptor (EGFR) mutation.

arizona-thes Repository record for Innovative Methods for Outcome-Based Pricing of Treatments from the US Payer Perspective (The Six Delta Platform) (opens in a new tab)

Implementation and Cost Analysis of Performing Molecular Assays using FFPE Tissue Blocks in the Clinical Laboratory at VA Palo Alto Health Care System

Comandante, Donna2017

… Care System, FFPE samples for BRAF, KRAS and EGFR mutation detection assays are usually sent out to reference laboratories. However, with the increasing demand and cost of these tests, it would be more cost effective to bring these assays to be performed in-house. The activities for this …

dominican Repository record for Implementation and Cost Analysis of Performing Molecular Assays using FFPE Tissue Blocks in the Clinical Laboratory at VA Palo Alto Health Care System (opens in a new tab)

Epidermal growth factor and Transforming growth factor α motogenic activities are mediated by Epidermal growth factor receptor : Identification of signalling pathways involved in head and neck cancer

Thwe, Aye MyatUniversity of Dundee2020

… alteration of Epidermal Growth Factor Receptor (EGFR) plays a major role in the development of Head and Neck cancer. However, the only FDA approved EGFR target for this neoplasm is the drug Cetuximab. Cetuximab can only be used where there is an over-expression of EGFR. Cetuximab works by …

dundee Repository record for Epidermal growth factor and Transforming growth factor α motogenic activities are mediated by Epidermal growth factor receptor : Identification of signalling pathways involved in head and neck cancer (opens in a new tab)

c-Met als prognostischer Biomarker im EGFR-mutierten nichtkleinzelligen Lungenkarzinom

Meyer, Anne-SophieUniversität Ulm

ulm-diss Repository record for c-Met als prognostischer Biomarker im EGFR-mutierten nichtkleinzelligen Lungenkarzinom (opens in a new tab)

Characterization of mTOR Inhibition and Autophagy Inhibition in Non-Small Cell Lung Cancer

Britt, Rebecca2016

… RTK activation such as ERBB2 amplification or EGFR mutation or amplification, while KRAS and/or LKB1 mutations were associated with resistance. RNAi knockdown of various components related to mTOR signaling and autophagy produce a heterogeneous growth effect response in NSCLCs cells, and …

utswmed Repository record for Characterization of mTOR Inhibition and Autophagy Inhibition in Non-Small Cell Lung Cancer (opens in a new tab)